AffirmHealth Blog

Mario Ramirez, MD


Recent Posts

HHS Interagency Task Force on Pain Management Attracts Some Controversy

Posted by Mario Ramirez, MD on Feb 12, 2019 3:00:00 PM

0 Comments

 

Task Force Releases Draft Report

The Comprehensive Addiction and Recovery Act of 2016 established a Pain Management Best Practices Inter-Agency Task Force, chaired by Dr. Vanila Singh, under the oversight of the U.S. Department of Health and Human Services.

The Task Force is made up of representatives from across HHS, the Departments of Veterans Affairs and Defense, the Office of National Drug Control Policy, and non-federal representatives from experts and stakeholder groups. It is charged with delivering their final report to Congress in 2019, but released their draft findings in early January this year. The report is open for a 90-day comment and public input period before the draft will be revised and submitted to Congress later this year.

READ MORE

Talking to Your Patients About Opioid Abuse: A Clinician’s Guide

Posted by Mario Ramirez, MD on Jan 16, 2019 9:08:02 AM

0 Comments

At AffirmHealth, our work focuses around working with clinicians to ensure that they are prescribing opioids in a reliable and compliant manner that gives administrators insight into what is happening across their organizations.  From the clinician’s viewpoint, my job is to help ensure that the clinical information and the decision support we implement works in a way that actually improves care delivery to the patient—after all, if our work isn’t actually making care better, then we’re doing a disservice to the patient.  While our blog has covered a wide range of critical issues around these topics, one thing we’ve never actually discussed is how clinicians should approach the topic of opioid abuse with their patients, strategies for successful risk screening, and what to do if one of your patients develops an opioid use disorder.

READ MORE

The Opioid Epidemic at the End of 2018: Are We Making Progress?

Posted by Mario Ramirez, MD on Dec 11, 2018 9:31:00 AM

0 Comments

For those of us involved in the opioid epidemic as caregivers, patient advocates, and researchers, there was an interesting moment earlier this year when a series of news stories noted some optimism in the fight against overdose deaths. 

In mid-October, Health and Human Services Secretary Alex Azar commented on preliminary data from the U.S. Centers for Disease Control and Prevention that suggested “that the U.S. may be ‘beginning to turn the tide’ on the opioid crisis.[1]”  “The seemingly relentless trend of rising overdose deaths seems to be finally bending in the right direction…We are so far from the end of the epidemic, but we are perhaps at the end of the beginning.[2]” 

READ MORE
dsuvia, FDA, Raeford Brown, Opioid Therapy, Opioid Epidemic

The Controversial Approval of Dsuvia by the Food and Drug Administration

Posted by Mario Ramirez, MD on Nov 21, 2018 8:23:13 AM

0 Comments

Earlier this month on November 2nd, the U.S. Food and Drug Administration approved Dsuvia, a new sublingual version of an older drug, sufentanil, that has been in use since 1984. 

READ MORE

An Update on Provider Education Efforts and the Opioid Epidemic

Posted by Mario Ramirez, MD on Oct 23, 2018 1:54:07 PM

0 Comments

A Focus on Opioid Education Efforts

READ MORE

An Update on National Naloxone Distribution Efforts

Posted by Mario Ramirez, MD on Oct 2, 2018 9:30:00 AM

0 Comments

At AffirmHealth, we’ve directed much of our blog content towards safe and responsible opioid prescribing practices with an emphasis on the application of state and federal guidelines to daily clinician activities. 

READ MORE
clinical practice improvement activities, clinical decision support, electronic decisions support, clinicians

Implementing Opioid Management Guidelines Through Electronic Decision Support: A Clinician’s View

Posted by Mario Ramirez, MD on Aug 1, 2018 10:01:00 AM

0 Comments

“The volume and complexity of what we know has exceeded our individual ability to deliver its benefits correctly, safely, or reliably. Knowledge has both saved us and burdened us.”—Atul Guwande.[1]

READ MORE
Opioid Prescribing Guidelines, prescribing protocols, prescriber compliance

Three, Five, and Seven Day-Opioid Limits:  Where Do They Come From and Why You Should Care

Posted by Mario Ramirez, MD on Jun 12, 2018 10:00:00 AM

0 Comments

READ MORE

 

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

PROTECT YOUR PATIENTS.
PROTECT YOUR PRACTICE.

Drive responsible, compliant opioid prescribing across your organization.

SCHEDULE A CALL

Comments

Categories

see all

Popular Posts